Cells (Sep 2021)

Exendin-4 Pretreatment Attenuates Kainic Acid-Induced Hippocampal Neuronal Death

  • Yu-Jeong Ahn,
  • Hyun-Joo Shin,
  • Eun-Ae Jeong,
  • Hyeong-Seok An,
  • Jong-Youl Lee,
  • Hye-Min Jang,
  • Kyung-Eun Kim,
  • Jaewoong Lee,
  • Meong-Cheol Shin,
  • Gu-Seob Roh

DOI
https://doi.org/10.3390/cells10102527
Journal volume & issue
Vol. 10, no. 10
p. 2527

Abstract

Read online

Exendin-4 (Ex-4) is a glucagon-like peptide-1 receptor (GLP-1R) agonist that protects against brain injury. However, little is known about the effect of Ex-4 on kainic acid (KA)-induced seizures and hippocampal cell death. Therefore, this study evaluated the neuroprotective effects of Ex-4 pretreatment in a mouse model of KA-induced seizures. Three days before KA treatment, mice were intraperitoneally injected with Ex-4. We found that Ex-4 pretreatment reversed KA-induced reduction of GLP-1R expression in the hippocampus and attenuated KA-induced seizure score, hippocampal neuronal death, and neuroinflammation. Ex-4 pretreatment also dramatically reduced hippocampal lipocalin-2 protein in KA-treated mice. Furthermore, immunohistochemical studies showed that Ex-4 pretreatment significantly alleviated blood–brain barrier leakage. Finally, Ex-4 pretreatment stimulated hippocampal expression of phosphorylated cyclic adenosine monophosphate (cAMP) response element-binding protein (p-CREB), a known target of GLP-1/GLP-1R signaling. These findings indicate that Ex-4 pretreatment may protect against KA-induced neuronal damage by regulating GLP-1R/CREB-mediated signaling pathways.

Keywords